Core Laboratories N.V. (CLB) Reports In-Line Q2 EPS, Updates Guidance

Core Laboratories N.V. (NYSE: CLB) reported Q2 EPS of $1.32, in-line with the analyst estimate of $1.32. Revenue for the quarter came in at $263.1 million versus the consensus estimate of $267.24 million.

Core Laboratories N.V. sees Q3 2013 EPS of $1.33-1.34, versus the consensus of $1.34. Core Laboratories N.V. sees Q3 2013 revenue of $263-268 million, versus the consensus of $270.38 million.

Core Laboratories N.V. sees Q4 2013 EPS of $1.37-1.38, versus the consensus of $1.38. Core Laboratories N.V. sees Q4 2013 revenue of $268-270 million.

For earnings history and earnings-related data on Core Laboratories N.V. (CLB) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
• Boston Beer Co. (SAM) Tops Q3 EPS by 15c; offers guidance
• Caldwell sells IQTalent subsidiary to WinMil for C$4.7M